TreeWAS – Variant ID: rs7254215

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G12.2 Motor neuron disease	0.016	0.984	0.000
O03.9 Complete or unspecified, without complication	0.000	0.986	0.014
T36-T50 Poisoning by drugs, medicaments and biological substances	0.013	0.987	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.013	0.987	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.012	0.988	0.000
T42.4 Benzodiazepines	0.012	0.988	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.012	0.988	0.000
G12 Spinal muscular atrophy and related syndromes	0.012	0.988	0.000
T43.2 Other and unspecified antidepressants	0.012	0.988	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.012	0.988	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.011	0.989	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.011	0.989	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.011	0.989	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.011	0.989	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.011	0.989	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.010	0.990	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.010	0.990	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
T50.1 Loop [high-ceiling] diuretics	0.010	0.990	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.010	0.990	0.000
S61.9 Open wound of wrist and hand, part unspecified	0.010	0.990	0.000
Z51.8 Other specified medical care	0.010	0.990	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.010	0.990	0.000
T50.8 Diagnostic agents	0.009	0.990	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.009	0.990	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.009	0.990	0.000
T42.1 Iminostilbenes	0.009	0.990	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.009	0.991	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.009	0.991	0.000
T42.0 Hydantoin derivatives	0.009	0.991	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.009	0.991	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.009	0.991	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.009	0.991	0.000
T42.2 Succinimides and oxazolidinediones	0.009	0.991	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.009	0.991	0.000
T50.7 Analeptics and opioid receptor antagonists	0.009	0.991	0.000
T50.5 Appetite depressants	0.009	0.991	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.009	0.991	0.000
T50.0 Mineralocorticoids and their antagonists	0.009	0.991	0.000
G12.9 Spinal muscular atrophy, unspecified	0.009	0.991	0.000
G12.8 Other spinal muscular atrophies and related syndromes	0.009	0.991	0.000
G12.1 Other inherited spinal muscular atrophy	0.009	0.991	0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.009	0.991	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.009	0.991	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.009	0.991	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.009	0.991	0.000
T43.6 Psychostimulants with abuse potential	0.009	0.991	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.009	0.991	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.009	0.991	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.009	0.991	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.009	0.991	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.009	0.991	0.000
T44.0 Anticholinesterase agents	0.009	0.991	0.000
T36 Poisoning by systemic antibiotics	0.009	0.991	0.000
T43.9 Psychotropic drug, unspecified	0.008	0.991	0.000
T47.0 Histamine H(2)-receptor antagonists	0.008	0.991	0.000
T42.3 Barbiturates	0.008	0.991	0.000
T47.6 Antidiarrhoeal drugs	0.008	0.991	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.008	0.991	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.009	0.991	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.008	0.992	0.000
T47.2 Stimulant laxatives	0.008	0.992	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.008	0.992	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.008	0.992	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.008	0.992	0.000
T47.7 Emetics	0.008	0.992	0.000
T47.5 Digestants	0.008	0.992	0.000
T47.3 Saline and osmotic laxatives	0.008	0.992	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.008	0.992	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.008	0.992	0.000
T47.4 Other laxatives	0.008	0.992	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.008	0.992	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.008	0.992	0.000
G11 Hereditary ataxia	0.008	0.992	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.008	0.992	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.008	0.992	0.000
T46.7 Peripheral vasodilators	0.008	0.992	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.008	0.992	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.008	0.992	0.000
G14 Postpolio syndrome	0.008	0.992	0.000
G10 Huntington's disease	0.008	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.992	0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.008	0.992	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.008	0.992	0.000
T48.5 Anti-common-cold drugs	0.007	0.992	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.992	0.000
T46.1 Calcium-channel blockers	0.007	0.992	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.993	0.000
T37.5 Antiviral drugs	0.007	0.993	0.000
T37.4 Anthelminthics	0.007	0.993	0.000
T37.3 Other antiprotozoal drugs	0.007	0.993	0.000
T37.1 Antimycobacterial drugs	0.007	0.993	0.000
T37.0 Sulphonamides	0.007	0.993	0.000
T38.5 Other oestrogens and progestogens	0.007	0.993	0.000
T38.1 Thyroid hormones and substitutes	0.007	0.993	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.007	0.993	0.000
T48.4 Expectorants	0.007	0.993	0.000
T48.3 Antitussives	0.007	0.993	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.007	0.993	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.007	0.993	0.000
T48.0 Oxytocic drugs	0.007	0.993	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
T38.9 Other and unspecified hormone antagonists	0.007	0.993	0.000
T38.7 Androgens and anabolic congeners	0.007	0.993	0.000
T38.4 Oral contraceptives	0.007	0.993	0.000
T38.2 Antithyroid drugs	0.007	0.993	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.007	0.993	0.000
T41.5 Therapeutic gases	0.007	0.993	0.000
T41.4 Anaesthetic, unspecified	0.007	0.993	0.000
T41.3 Local anaesthetics	0.007	0.993	0.000
T41.2 Other and unspecified general anaesthetics	0.007	0.993	0.000
T41.1 Intravenous anaesthetics	0.007	0.993	0.000
T41.0 Inhaled anaesthetics	0.007	0.993	0.000
T45.0 Antiallergic and antiemetic drugs	0.007	0.993	0.000
O21.0 Mild hyperemesis gravidarum	0.000	0.993	0.007
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.007	0.993	0.000
T49.9 Topical agent, unspecified	0.007	0.993	0.000
T49.8 Other topical agents	0.007	0.993	0.000
T49.7 Dental drugs, topically applied	0.007	0.993	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.007	0.993	0.000
T49.5 Ophthalmological drugs and preparations	0.007	0.993	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.993	0.000
T49.3 Emollients, demulcents and protectants	0.007	0.993	0.000
T49.2 Local astringents and local detergents	0.007	0.993	0.000
T49.1 Antipruritics	0.007	0.993	0.000
T38.0 Glucocorticoids and synthetic analogues	0.007	0.993	0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.000	0.993	0.007
G11.9 Hereditary ataxia, unspecified	0.007	0.993	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
T36.0 Penicillins	0.007	0.993	0.000
T36.8 Other systemic antibiotics	0.006	0.993	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.007	0.993	0.000
L89.1 Stage II decubitus ulcer	0.007	0.993	0.000
T36.9 Systemic antibiotic, unspecified	0.006	0.993	0.000
T36.7 Antifungal antibiotics, systemically used	0.006	0.993	0.000
T36.6 Rifamycins	0.006	0.993	0.000
T36.5 Aminoglycosides	0.006	0.993	0.000
T36.2 Chloramphenicol group	0.006	0.993	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.993	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.006	0.993	0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.000	0.994	0.006
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease	0.006	0.994	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.006	0.994	0.000
T39.4 Antirheumatics, not elsewhere classified	0.006	0.994	0.000
T39.2 Pyrazolone derivatives	0.006	0.994	0.000
T36.4 Tetracyclines	0.006	0.994	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.006	0.994	0.000
T45.8 Other primarily systemic and haematological agents	0.006	0.994	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.006	0.994	0.000
T45.6 Fibrinolysis-affecting drugs	0.006	0.994	0.000
T45.3 Enzymes, not elsewhere classified	0.006	0.994	0.000
G13.0 Paraneoplastic neuromyopathy and neuropathy	0.006	0.994	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.006	0.994	0.000
T45.5 Anticoagulants	0.006	0.994	0.000
L89 Decubitus ulcer	0.006	0.994	0.000
E83.5 Disorders of calcium metabolism	0.000	0.994	0.006
G11.4 Hereditary spastic paraplegia	0.006	0.994	0.000
T45.4 Iron and its compounds	0.006	0.994	0.000
T45.2 Vitamins, not elsewhere classified	0.006	0.994	0.000
G11.8 Other hereditary ataxias	0.006	0.994	0.000
G11.3 Cerebellar ataxia with defective DNA repair	0.006	0.994	0.000
G11.2 Late-onset cerebellar ataxia	0.006	0.994	0.000
G11.0 Congenital nonprogressive ataxia	0.006	0.994	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.994	0.000
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere	0.006	0.994	0.000
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema	0.006	0.994	0.000
T36.3 Macrolides	0.006	0.994	0.000
G11.1 Early-onset cerebellar ataxia	0.005	0.994	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
L57.0 Actinic keratosis	0.005	0.995	0.000
N50.1 Vascular disorders of male genital organs	0.000	0.995	0.005
T40.6 Other and unspecified narcotics	0.005	0.995	0.000
I50.0 Congestive heart failure	0.005	0.995	0.000
T40.3 Methadone	0.005	0.995	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.005	0.995	0.000
T40.8 Lysergide [LSD]	0.005	0.995	0.000
T40.7 Cannabis (derivatives)	0.005	0.995	0.000
T40.0 Opium	0.005	0.995	0.000
T39.0 Salicylates	0.005	0.995	0.000
L89.3 Stage IV decubitus ulcer	0.005	0.995	0.000
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified	0.000	0.995	0.005
T40.2 Other opioids	0.005	0.995	0.000
O03 Spontaneous abortion	0.000	0.995	0.005
H50.9 Strabismus, unspecified	0.005	0.995	0.000
T40.5 Cocaine	0.004	0.995	0.000
T40.1 Heroin	0.004	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.995	0.000
H92.0 Otalgia	0.004	0.996	0.000
G30.9 Alzheimer's disease, unspecified	0.004	0.996	0.000
M31.6 Other giant cell arteritis	0.004	0.996	0.000
O21 Excessive vomiting in pregnancy	0.000	0.996	0.004
N95.2 Postmenopausal atrophic vaginitis	0.000	0.996	0.004
O03.3 Incomplete, with other and unspecified complications	0.000	0.996	0.004
L57 Skin changes due to chronic exposure to nonionising radiation	0.004	0.996	0.000
C09.9 Tonsil, unspecified	0.000	0.996	0.004
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.996	0.004
D06.9 Cervix, unspecified	0.000	0.996	0.004
C34.1 Upper lobe, bronchus or lung	0.004	0.996	0.000
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.000	0.996	0.004
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.004	0.996	0.000
O03.7 Complete or unspecified, complicated by embolism	0.000	0.996	0.003
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.996	0.003
O03.2 Incomplete, complicated by embolism	0.000	0.996	0.003
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.996	0.003
L89.2 Stage III decubitus ulcer	0.003	0.996	0.000
M54.36 Sciatica (Lumbar region)	0.000	0.996	0.004
H92.1 Otorrhoea	0.004	0.996	0.000
H81.1 Benign paroxysmal vertigo	0.000	0.996	0.004
L97 Ulcer of lower limb, not elsewhere classified	0.000	0.996	0.004
O21.1 Hyperemesis gravidarum with metabolic disturbance	0.000	0.996	0.003
H83.0 Labyrinthitis	0.000	0.997	0.003
H92 Otalgia and effusion of ear	0.003	0.997	0.000
O03.8 Complete or unspecified, with other and unspecified complications	0.000	0.997	0.003
O21.9 Vomiting of pregnancy, unspecified	0.000	0.997	0.003
K13.0 Diseases of lips	0.003	0.997	0.000
C77.0 Lymph nodes of head, face and neck	0.000	0.997	0.003
O21.2 Late vomiting of pregnancy	0.000	0.997	0.003
I97 Postprocedural disorders of circulatory system, not elsewhere classified	0.000	0.997	0.003
H83.8 Other specified diseases of inner ear	0.000	0.997	0.003
L57.4 Cutis laxa senilis	0.003	0.997	0.000
H83 Other diseases of inner ear	0.000	0.997	0.003
K22.7 Barrett's oesophagus	0.000	0.997	0.003
L57.3 Poikiloderma of Civatte	0.003	0.997	0.000
L57.2 Cutis rhomboidalis nuchae	0.003	0.997	0.000
L57.1 Actinic reticuloid	0.003	0.997	0.000
O21.8 Other vomiting complicating pregnancy	0.000	0.997	0.003
I97.2 Postmastectomy lymphoedema syndrome	0.000	0.997	0.003
M65.4 Radial styloid tenosynovitis [de Quervain]	0.000	0.997	0.003
C01 Malignant neoplasm of base of tongue	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.003	0.997	0.000
G95.2 Cord compression, unspecified	0.003	0.997	0.000
H81 Disorders of vestibular function	0.000	0.997	0.003
K13 Other diseases of lip and oral mucosa	0.003	0.997	0.000
L57.5 Actinic granuloma	0.003	0.997	0.000
K13.7 Other and unspecified lesions of oral mucosa	0.003	0.997	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.003	0.997	0.000
L56 Other acute skin changes due to ultraviolet radiation	0.003	0.997	0.000
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.997	0.003
E83 Disorders of mineral metabolism	0.000	0.997	0.003
H50.5 Heterophoria	0.003	0.997	0.000
H50 Other strabismus	0.003	0.997	0.000
H83.9 Disease of inner ear, unspecified	0.000	0.997	0.003
E83.3 Disorders of phosphorus metabolism	0.000	0.997	0.003
C09 Malignant neoplasm of tonsil	0.000	0.997	0.003
I97.0 Postcardiotomy syndrome	0.000	0.997	0.003
H92.2 Otorrhagia	0.003	0.997	0.000
K13.4 Granuloma and granuloma-like lesions of oral mucosa	0.003	0.997	0.000
H46 Optic neuritis	0.000	0.997	0.003
K13.6 Irritative hyperplasia of oral mucosa	0.003	0.997	0.000
O03.4 Incomplete, without complication	0.000	0.997	0.003
H81.3 Other peripheral vertigo	0.000	0.997	0.003
H81.8 Other disorders of vestibular function	0.000	0.997	0.003
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.003	0.997	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.003	0.997	0.000
N90.4 Leukoplakia of vulva	0.000	0.997	0.003
N90 Other noninflammatory disorders of vulva and perineum	0.000	0.997	0.003
H81.4 Vertigo of central origin	0.000	0.997	0.003
K13.5 Oral submucous fibrosis	0.003	0.997	0.000
N05.9 Unspecified	0.000	0.997	0.003
G30 Alzheimer's disease	0.003	0.997	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.002	0.997	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.997	0.003
H81.0 Meniere's disease	0.000	0.997	0.003
H83.1 Labyrinthine fistula	0.000	0.997	0.002
I97.1 Other functional disturbances following cardiac surgery	0.000	0.997	0.002
N83.1 Corpus luteum cyst	0.003	0.997	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.997	0.002
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.002	0.997	0.000
C18.0 Caecum	0.002	0.998	0.000
H57.1 Ocular pain	0.002	0.998	0.000
H50.4 Other and unspecified heterotropia	0.002	0.998	0.000
I97.9 Postprocedural disorder of circulatory system, unspecified	0.000	0.998	0.002
U89.8 Agent resistant to other single specified antibiotic	0.000	0.998	0.002
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec	0.000	0.998	0.002
M65.48 Radial styloid tenosynovitis [de Quervain]-Other	0.000	0.998	0.002
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot	0.000	0.998	0.002
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg	0.000	0.998	0.002
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh	0.000	0.998	0.002
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm	0.000	0.998	0.002
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region	0.000	0.998	0.002
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)	0.000	0.998	0.002
K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue	0.002	0.998	0.000
K13.3 Hairy leukoplakia	0.002	0.998	0.000
L56.4 Polymorphous light eruption	0.002	0.998	0.000
M81.40 Drug-induced osteoporosis (Multiple sites)	0.002	0.998	0.000
H83.3 Noise effects on inner ear	0.000	0.998	0.002
N90.0 Mild vulvar dysplasia	0.000	0.998	0.002
L58 Radiodermatitis	0.002	0.998	0.000
H83.2 Labyrinthine dysfunction	0.000	0.998	0.002
N90.1 Moderate vulvar dysplasia	0.000	0.998	0.002
H50.6 Mechanical strabismus	0.002	0.998	0.000
H50.1 Divergent concomitant strabismus	0.002	0.998	0.000
K13.1 Cheek and lip biting	0.002	0.998	0.000
L56.3 Solar urticaria	0.002	0.998	0.000
L56.2 Photocontact dermatitis [berloque dermatitis]	0.002	0.998	0.000
L56.1 Drug photoallergic response	0.002	0.998	0.000
L56.0 Drug phototoxic response	0.002	0.998	0.000
E83.8 Other disorders of mineral metabolism	0.000	0.998	0.002
E83.2 Disorders of zinc metabolism	0.000	0.998	0.002
E83.0 Disorders of copper metabolism	0.000	0.998	0.002
H50.2 Vertical strabismus	0.002	0.998	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.998	0.002
H80-H83 Diseases of inner ear	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.000	0.998	0.002
H50.3 Intermittent heterotropia	0.002	0.998	0.000
N90.6 Hypertrophy of vulva	0.000	0.998	0.002
C09.8 Overlapping lesion of tonsil	0.000	0.998	0.002
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.998	0.002
H35.3 Degeneration of macula and posterior pole	0.000	0.998	0.002
Z36.9 Antenatal screening, unspecified	0.000	0.998	0.002
G30.1 Alzheimer's disease with late onset	0.002	0.998	0.000
L55 Sunburn	0.002	0.998	0.000
N90.2 Severe vulvar dysplasia, not elsewhere classified	0.000	0.998	0.002
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.002	0.998	0.000
U80.1 Methicillin resistant agent	0.000	0.998	0.002
C09.1 Tonsillar pillar (anterior) (posterior)	0.000	0.998	0.002
M31.3 Wegener's granulomatosis	0.002	0.998	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.998	0.002
C09.0 Tonsillar fossa	0.000	0.998	0.002
L58.9 Radiodermatitis, unspecified	0.002	0.998	0.000
C00.1 External lower lip	0.000	0.998	0.002
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.998	0.002
H47.2 Optic atrophy	0.000	0.998	0.002
Z99.1 Dependence on respirator	0.002	0.998	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.000	0.998	0.002
U80.0 Penicillin resistant agent	0.000	0.998	0.002
M31 Other necrotising vasculopathies	0.002	0.998	0.000
C00 Malignant neoplasm of lip	0.000	0.998	0.002
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)	0.000	0.998	0.002
G30.8 Other Alzheimer's disease	0.002	0.998	0.000
H93.1 Tinnitus	0.002	0.998	0.000
H50.8 Other specified strabismus	0.002	0.998	0.000
N90.3 Dysplasia of vulva, unspecified	0.000	0.998	0.002
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.002	0.998	0.000
K13.29 Other disturbances of oral epithelium, including tongue	0.002	0.998	0.000
H81.2 Vestibular neuronitis	0.000	0.998	0.002
C13 Malignant neoplasm of hypopharynx	0.000	0.998	0.002
L58.1 Chronic radiodermatitis	0.002	0.998	0.000
L58.0 Acute radiodermatitis	0.002	0.998	0.000
M84.03 Malunion of fracture (Forearm)	0.000	0.998	0.002
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.000	0.998	0.002
O02.1 Missed abortion	0.000	0.998	0.002
G30.0 Alzheimer's disease with early onset	0.002	0.998	0.000
H81.9 Disorder of vestibular function, unspecified	0.000	0.998	0.002
H82 Vertiginous syndromes in diseases classified elsewhere	0.000	0.998	0.002
M31.4 Aortic arch syndrome [Takayasu]	0.002	0.998	0.000
N90.5 Atrophy of vulva	0.000	0.998	0.002
C13.0 Postcricoid region	0.000	0.998	0.002
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.998	0.002
N88.2 Stricture and stenosis of cervix uteri	0.000	0.998	0.002
C12 Malignant neoplasm of pyriform sinus	0.000	0.998	0.002
C07 Malignant neoplasm of parotid gland	0.000	0.998	0.002
F17.2 Dependence syndrome	0.002	0.998	0.000
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.000	0.998	0.002
L55.9 Sunburn, unspecified	0.002	0.998	0.000
L55.8 Other sunburn	0.002	0.998	0.000
L55.2 Sunburn of third degree	0.002	0.998	0.000
L55.1 Sunburn of second degree	0.002	0.998	0.000
L55.0 Sunburn of first degree	0.002	0.998	0.000
D69.9 Haemorrhagic condition, unspecified	0.000	0.998	0.002
C08 Malignant neoplasm of other and unspecified major salivary glands	0.000	0.998	0.002
M31.7 Microscopic polyangiitis	0.002	0.998	0.000
C05 Malignant neoplasm of palate	0.000	0.998	0.002
C03 Malignant neoplasm of gum	0.000	0.998	0.002
C00.0 External upper lip	0.000	0.998	0.002
M31.9 Necrotising vasculopathy, unspecified	0.002	0.998	0.000
M31.2 Lethal midline granuloma	0.002	0.998	0.000
T83.3 Mechanical complication of intra-uterine contraceptive device	0.002	0.998	0.000
I98 Other disorders of circulatory system in diseases classified elsewhere	0.000	0.998	0.002
O34.2 Maternal care due to uterine scar from previous surgery	0.002	0.998	0.000
C11 Malignant neoplasm of nasopharynx	0.000	0.998	0.002
C00.8 Overlapping lesion of lip	0.000	0.998	0.002
C00.6 Commissure of lip	0.000	0.998	0.002
C00.5 Lip, unspecified, inner aspect	0.000	0.998	0.002
C00.4 Lower lip, inner aspect	0.000	0.998	0.002
C00.3 Upper lip, inner aspect	0.000	0.998	0.002
C00.2 External lip, unspecified	0.000	0.998	0.002
I73.0 Raynaud's syndrome	0.000	0.998	0.002
C13.9 Hypopharynx, unspecified	0.000	0.998	0.002
L59.0 Erythema ab igne [dermatitis ab igne]	0.001	0.998	0.000
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.002	0.998	0.000
C13.8 Overlapping lesion of hypopharynx	0.000	0.998	0.002
C13.2 Posterior wall of hypopharynx	0.000	0.998	0.002
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.000	0.998	0.002
O00-O08 Pregnancy with abortive outcome	0.000	0.998	0.002
C05.9 Palate, unspecified	0.000	0.998	0.002
M31.8 Other specified necrotising vasculopathies	0.002	0.998	0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.002	0.998	0.000
Z34.9 Supervision of normal pregnancy, unspecified	0.000	0.998	0.002
O02 Other abnormal products of conception	0.000	0.998	0.002
K45.8 Other specified abdominal hernia without obstruction or gangrene	0.002	0.998	0.000
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.001	0.998	0.000
C00.9 Lip, unspecified	0.000	0.998	0.001
C08.0 Submandibular gland	0.000	0.998	0.001
U89 Agent resistant to other and unspecified antibiotics	0.000	0.998	0.002
M10.97 Gout, unspecified (Ankle and foot)	0.002	0.998	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.000	0.998	0.001
C03.0 Upper gum	0.000	0.998	0.001
C05.0 Hard palate	0.000	0.998	0.001
H74.0 Tympanosclerosis	0.002	0.998	0.000
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
C04 Malignant neoplasm of floor of mouth	0.000	0.998	0.001
C03.1 Lower gum	0.000	0.998	0.001
C05.8 Overlapping lesion of palate	0.000	0.998	0.001
C05.2 Uvula	0.000	0.998	0.001
C08.8 Overlapping lesion of major salivary glands	0.000	0.998	0.001
C08.1 Sublingual gland	0.000	0.998	0.001
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.001	0.998	0.000
M31.0 Hypersensitivity angiitis	0.001	0.998	0.000
N05.8 Other	0.000	0.998	0.002
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.002	0.998	0.000
D06 Carcinoma in situ of cervix uteri	0.000	0.998	0.002
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.998	0.002
G30-G32 Other degenerative diseases of the nervous system	0.002	0.998	0.000
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.000	0.998	0.002
M31.1 Thrombotic microangiopathy	0.001	0.998	0.000
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.002	0.998	0.000
C10 Malignant neoplasm of oropharynx	0.000	0.998	0.001
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.002	0.998	0.000
C08.9 Major salivary gland, unspecified	0.000	0.998	0.001
H72.0 Central perforation of tympanic membrane	0.002	0.998	0.000
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere	0.000	0.998	0.001
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
I98.0 Cardiovascular syphilis	0.000	0.998	0.001
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.002	0.998	0.000
M54.64 Pain in thoracic spine (Thoracic region)	0.000	0.998	0.002
C11.9 Nasopharynx, unspecified	0.000	0.998	0.001
C11.8 Overlapping lesion of nasopharynx	0.000	0.998	0.001
C11.3 Anterior wall of nasopharynx	0.000	0.998	0.001
C11.2 Lateral wall of nasopharynx	0.000	0.998	0.001
C11.0 Superior wall of nasopharynx	0.000	0.998	0.001
T83.0 Mechanical complication of urinary (indwelling) catheter	0.002	0.998	0.000
H93 Other disorders of ear, not elsewhere classified	0.002	0.998	0.000
H46-H48 Disorders of optic nerve and visual pathways	0.000	0.998	0.002
G31.0 Circumscribed brain atrophy	0.001	0.998	0.000
N05 Unspecified nephritic syndrome	0.000	0.998	0.002
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.998	0.001
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract	0.001	0.998	0.000
V89.9 Person injured in unspecified vehicle accident	0.000	0.998	0.001
Z63.4 Disappearance and death of family member	0.000	0.998	0.001
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.002	0.998	0.000
G95 Other diseases of spinal cord	0.002	0.998	0.000
O06 Unspecified abortion	0.000	0.998	0.001
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.000	0.998	0.001
C11.1 Posterior wall of nasopharynx	0.000	0.998	0.001
H93.8 Other specified disorders of ear	0.001	0.998	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.000	0.998	0.001
O02.9 Abnormal product of conception, unspecified	0.000	0.998	0.001
O02.8 Other specified abnormal products of conception	0.000	0.998	0.001
O07 Failed attempted abortion	0.000	0.998	0.001
O05 Other abortion	0.000	0.998	0.001
C03.9 Gum, unspecified	0.000	0.999	0.001
D68.8 Other specified coagulation defects	0.000	0.999	0.001
G95.9 Disease of spinal cord, unspecified	0.001	0.999	0.000
T83.9 Unspecified complication of genito-urinary prosthetic device, implant and graft	0.001	0.999	0.000
T83.2 Mechanical complication of graft of urinary organ	0.001	0.999	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.000	0.999	0.001
D06.1 Exocervix	0.000	0.999	0.001
O04.4 Incomplete, without complication	0.000	0.999	0.001
C05.1 Soft palate	0.000	0.999	0.001
C14.2 Waldeyer's ring	0.000	0.999	0.001
C04.8 Overlapping lesion of floor of mouth	0.000	0.999	0.001
C04.1 Lateral floor of mouth	0.000	0.999	0.001
C18.5 Splenic flexure	0.000	0.999	0.001
D07.5 Prostate	0.001	0.999	0.000
K76.6 Portal hypertension	0.000	0.999	0.001
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.001	0.999	0.000
O01 Hydatidiform mole	0.000	0.999	0.001
M10.96 Gout, unspecified (Lower leg)	0.001	0.999	0.000
C04.0 Anterior floor of mouth	0.000	0.999	0.001
D06.7 Other parts of cervix	0.000	0.999	0.001
G31.2 Degeneration of nervous system due to alcohol	0.001	0.999	0.000
H47.7 Disorder of visual pathways, unspecified	0.000	0.999	0.001
H47.6 Disorders of visual cortex	0.000	0.999	0.001
H47.4 Disorders of optic chiasm	0.000	0.999	0.001
H50.0 Convergent concomitant strabismus	0.001	0.999	0.000
O44.1 Placenta praevia with haemorrhage	0.001	0.999	0.000
C02.4 Lingual tonsil	0.000	0.999	0.001
C10.8 Overlapping lesion of oropharynx	0.000	0.999	0.001
C10.4 Branchial cleft	0.000	0.999	0.001
C10.3 Posterior wall of oropharynx	0.000	0.999	0.001
C10.2 Lateral wall of oropharynx	0.000	0.999	0.001
C10.1 Anterior surface of epiglottis	0.000	0.999	0.001
C10.0 Vallecula	0.000	0.999	0.001
O06.4 Incomplete, without complication	0.000	0.999	0.001
C02 Malignant neoplasm of other and unspecified parts of tongue	0.000	0.999	0.001
O08 Complications following abortion and ectopic and molar pregnancy	0.000	0.999	0.001
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.999	0.001
M25.84 Other specified joint disorders (Hand)	0.001	0.999	0.000
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.000	0.999	0.001
H93.2 Other abnormal auditory perceptions	0.001	0.999	0.000
H93.0 Degenerative and vascular disorders of ear	0.001	0.999	0.000
T83.1 Mechanical complication of other urinary devices and implants	0.001	0.999	0.000
D69 Purpura and other haemorrhagic conditions	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations